Skip to main content
. 2022 May 14;26(6):564–570. doi: 10.1007/s12603-022-1800-1

Table 2.

Associations between apelin and evolution in sarcopenia determinants

Model Sample size Apelin Coefficient p-value 95% CI Time Coefficient p-value 95% CI Apelin x Time Coefficient p-value 95% CI
ALM Model 1* 118 −4.9E-04 0.0686 −1.01E-03, 3.7E-05 0.1666 0.2786 −0.1357, 0.4689 3.4E-05 0.6692 −1.2E-04, 1.88E-04
Model 2¥ 118 −3.7E-04 0.1387 −8.6E-04, 1.21E-04 0.1334 0.3825 −0.1670, 0.4337 5.8E-05 0.4570 −1.0E-04, 2.12E-04
Grip Strength Model 1 118 −5.8E-04 0.3023 −1.67E-03, 5.21E-04 −3.5504 <0.0001 −4.3206, −2.7802 −1.2E-04 0.5597 −5.1E-04, 2.77E-04
Model 2 118 −5.3E-04 0.3507 −1.65E-03, 5.86E-04 −3.5837 <0.0001 −4.3513, −2.8161 −1.1E-04 0.5754 −5.0E-04, 2.8E-04
Gait Speed Model 1 118 3.1E-05 0.1414 −1.0E-05, 7.3E-05 −0.01324 0.3749 −0.04270, 0.01622 6.4E-06 0.3986 −8.62E-06, 2.2E-05
Model 2 118 2.5E-05 0.2450 −2.0E-05, 6.7E-05 −0.00927 0.5408 −0.03924, 0.02070 5.1E-06 0.5122 −1.0E-05, 2.0E-05

Abbreviations: ALM= Appendicular Lean Mass, CI= confidence interval; *Adjusted by age and sex; ¥Adjusted by age, sex, body mass index, MAPT group, vascular risk, physical activity levels and interleukin-6 levels.